Oral Vitamin K Prophylaxis in Newborns: A Survey of Clinician Opinions and Practices
| Autor: | Laura R. Kair, Kelly E. Wood, Jessica H. Cheng, Jaspreet Loyal |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
Parents Pediatrics Health Knowledge Attitudes Practice Vitamin K Vitamin k California chemistry.chemical_compound 0302 clinical medicine Surveys and Questionnaires Infant Mortality 030212 general & internal medicine Research Articles Pediatric Practice Academic Medical Centers Incidence (epidemiology) Health Knowledge General Medicine Vitamin K Deficiency Bleeding Antifibrinolytic Agents Public Health and Health Services Female Vitamin medicine.medical_specialty Clinical Sciences MEDLINE 03 medical and health sciences Rare Diseases 030225 pediatrics medicine Humans Nutrition Extramural business.industry Prevention Infant Newborn Infant Newborn Iowa Connecticut chemistry Attitudes Pediatrics Perinatology and Child Health Oral vitamin Neonatology business Digestive Diseases |
| Zdroj: | Hosp Pediatr Hospital pediatrics, vol 10, iss 2 |
| ISSN: | 2154-1671 |
| Popis: | OBJECTIVES: The majority of newborns in the United States receive intramuscular (IM) vitamin K for prophylaxis against vitamin K deficiency bleeding (VKDB). Oral vitamin K is less effective than IM vitamin K in preventing VKDB but is widely used in Europe and by some in the United States when parents refuse IM vitamin K for their newborn. Our aim was to assess the practices, opinions, and knowledge of newborn clinicians regarding oral vitamin K prophylaxis when parents refuse IM vitamin K. METHODS: We conducted an electronic survey of newborn clinicians from 3 academic medical centers in California, Iowa, and Connecticut. Descriptive statistics and χ2 tests were performed. RESULTS: Of 160 newborn clinicians at 3 sites, 110 (69%) completed the survey. Of respondents, 58 (53%) believed the incidence of IM vitamin K refusal is increasing and had prescribed or recommended oral vitamin K at least once. Regarding knowledge, 32 (28%) and 23 (20%) respondents did not know whether oral vitamin K decreases the risk of early- and late-onset VKDB, respectively. There were no significant differences in opinions, knowledge, or practices across institutions or practice settings (NICU, well-newborn nursery, or both) (P > .05). CONCLUSIONS: Our study findings suggest that newborn clinicians may lack knowledge about the effectiveness of oral vitamin K in preventing VKDB. More information is needed about oral vitamin K regimens and outcomes of newborns who receive oral vitamin K. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|